SEC Form 4 · accession 0001385508-18-000098
OPIANT PHARMACEUTICALS, INC. · OPNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A Collard
Director
Period of report
Oct 29, 2018
Accepted (ET)
Oct 31, 2018 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385508
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common StockF1 | $17.61 | Oct 29, 2018 | A | 5,000 | A | — | Oct 29, 2028 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1On October 29, 2018, the reporting person was granted an option to purchase 5,000 shares of common stock. The options vest as follows: 33% of the options vest on the first, second and third anniversary of the grant date.